No Data
Cogent and ModivCare Gain After Insider Purchases
Why We're Not Concerned Yet About Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) 26% Share Price Plunge
Avadel Pharmaceuticals Plc (NASDAQ:AVDL) Has Found A Path To Profitability
UBS Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Cuts Target Price to $14
A Quick Look at Today's Ratings for Avadel Pharmaceuticals(AVDL.US), With a Forecast Between $13 to $22
Avadel Pharmaceuticals Is Maintained at Overweight by Piper Sandler